The prevention and treatment of dysplasia in gastroesophageal reflux disease: The results and the challenges ahead

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue SUPPL. 1, 2002, Pages

  Weinstein, Wilfred M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; NONSTEROID ANTIINFLAMMATORY AGENT; PHOTOFRIN; PLACEBO;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CANCER MORTALITY; CANCER RISK; CANCER SURGERY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DYSPLASIA; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTROINTESTINAL REFLUX; HUMAN; LASER SURGERY; MORBIDITY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0036111719     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.17.s1.9.x     Document Type: Conference Paper

References (81)

1. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review
2. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years
3. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?
4. Precursor lesions for gastric cardia cancer
5. Chronic nonatropic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study
6. Observer variation in the diagnosis of dysplasia in Barrett's esophagus
7. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation
8. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
9. High-grade dysplasia in Barrett's esophagus: Surveillance or operation?
10. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
11. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia
12. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia
13. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett's esophagus
14. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
15. The economic impact of the diagnosis of dysplasia in Barrett's esophagus
16. Barrett's-related esophageal adenocarcinoma: Is chemoprevention a potential option?
17. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
18. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion
19. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
20. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression
21. Maximal acid reflux control for Barrett's oesophagus: Feasible and effective
22. Long-term outcome of antireflux surgery in patients with barrett's esophagus
23. Antireflux surgery in the management of Barrett's esophagus
24. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease - Follow-up of a randomized controlled trial
25. A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time?
26. Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: Clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation
27. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
28. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database
29. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
30. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
31. Cyclooxygenase-2 expression in Barrett's esophagus
32. The diagnosis and management of Barrett's esophagus
33. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem
34. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus
35. Minimally invasive esophagectomy
36. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia
37. Disputing dysplasia
38. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma
39. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets
40. The quality of care in Barrett's esophagus: Endoscopist and pathologist practices
41. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus
42. Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy
43. Photothermal laser ablation of Barrett's oesophagus: Endoscopic and histological evidence of squamous re-epithelialisation
44. The histopathology of treated Barrett's esophagus: Squamous reepithelialization after acid suppression and laser and photodynamic therapy
45. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery
46. Complete regression of Barrett's esophagus with heat probe thermocoagulation: Mid-term results
47. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: Immediate and mid term results
48. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus
49. Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: A multicenter study
50. High power setting argon plasma coagulation for the eradication of Barrett's esophagus
51. Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus
52. The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus
53. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
54. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
55. Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX
56. Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid
57. Photodynamic therapy for dysplastic Barrett's oesophagus: A prospective, double blind, randomised, placebo controlled trial
58. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus
59. Predicting who will develop cancer: Role of biopsy, flow cytometry, cell and genetic markers
60. Methylene blue staining: Is it really useful in Barrett's esophagus?
61. Screening for specialized columnar epithelium with methylene blue: Chromoendoscopy in patients with Barrett's esophagus and a normal control group
62. Methylene blue staining and endoscopic ultrasound evaluation of Barrett's esophagus with low-grade dysplasia
63. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy
64. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus
65. Light-induced fluorescence endoscopy of the gastrointestinal tract
66. Long-term effects of photodynamic therapy on fluorescence spectroscopy in the human esophagus
67. A preliminary pharmacokinetic study of intravenous Photofrin in patients
68. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus
69. Optical coherence tomography of the esophagus and proximal stomach in health and disease
70. High-resolution endoscopic imaging of the GI tract using optical coherence tomography
71. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma
72. KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus
73. Endoscopic cryotherapy: Experimental results and first clinical use
74. Ultrasonic epithelial ablation of the lower esophagus without stricture formation. A new technique for Barrett's ablation
75. Endoscopic mucosal resection for esophageal and gastric mucosal cancers
76. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus
77. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression
78. Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus
79. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole
80. Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: A prospective study